Further validation using the external dataset GSE118370 showed that CDK1, TOP2A, TPX2, CENPF, and AURKA exhibited strong diagnostic capabilities for NSCLC, with each gene achieving an AUC greater than 0.8 (Fig. 6E). This evidence concerns the gene AURKA and non-small cell lung carcinoma.